As of April 18, 2025, Harvard Bioscience (HBIO) has a market cap of $17.101 million USD. According to our data, Harvard Bioscience is ranked No.8615 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $17.10 M |
-81.42%
|
Dec 31, 2024 | $92.03 M |
-60.56%
|
Dec 29, 2023 | $0.23 B |
93.14%
|
Dec 30, 2022 | $0.12 B |
-60.71%
|
Dec 31, 2021 | $0.31 B |
64.34%
|
Dec 31, 2020 | $0.19 B |
40.66%
|
Dec 31, 2019 | $0.13 B |
-4.09%
|
Dec 31, 2018 | $0.14 B |
-3.64%
|
Dec 29, 2017 | $0.14 B |
8.20%
|
Dec 30, 2016 | $0.13 B |
-12.10%
|
Dec 31, 2015 | $0.15 B |
-38.80%
|
Dec 31, 2014 | $0.25 B |
20.64%
|
Dec 31, 2013 | $0.20 B |
41.54%
|
Dec 31, 2012 | $0.14 B |
13.18%
|
Dec 30, 2011 | $0.13 B |
-5.15%
|
Dec 31, 2010 | $0.13 B |
14.29%
|
Dec 31, 2009 | $0.12 B |
34.72%
|
Dec 31, 2008 | $87.63 M |
-42.14%
|
Dec 31, 2007 | $0.15 B |
-10.72%
|
Dec 29, 2006 | $0.17 B |
15.28%
|
Dec 30, 2005 | $0.15 B |
-3.89%
|
Dec 31, 2004 | $0.15 B |
-47.98%
|
Dec 31, 2003 | $0.29 B |
170.52%
|
Dec 31, 2002 | $0.11 B |
-66.90%
|
Dec 31, 2001 | $0.33 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Bio-Rad Laboratories
BIO
|
$6.69 B |
1.227 B
|
![]() USA
|
![]() Thermo Fisher Scientific
TMO
|
$161.38 B |
-0.001 M
|
![]() USA
|
![]() Agilent Technologies
A
|
$29.22 B |
0.001 M
|
![]() USA
|
![]() Danaher
DHR
|
$133.67 B |
-0.001 M
|
![]() USA
|
![]() Illumina
ILMN
|
$11.27 B |
-0.000 M
|
![]() USA
|
![]() Waters Corporation
WAT
|
$19.10 B |
-0.000 M
|
![]() USA
|
![]() Bruker
BRKR
|
$5.50 B |
-0.000 M
|
![]() USA
|
![]() Qiagen
QGEN
|
$8.80 B |
-0.000 M
|
![]() Netherlands
|
![]() Mettler-Toledo
MTD
|
$20.94 B |
-0.000 M
|
![]() USA
|
![]() Charles River Laboratories
CRL
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() Becton Dickinson
BDX
|
$57.06 B |
0.001 M
|
![]() USA
|
Market Cap | = | HBIO Stock Price | * | HBIO Shares Outstanding |
= | $0.39 | * | 44.07 M | |
= | $17.10 M |